Karl Egger Selected Research

Karl Egger Research Topics

Disease

3	Stroke (Strokes) 08/2021 - 06/2018
3	Brain Neoplasms (Brain Tumor) 06/2020 - 06/2015
3	Neoplasm Metastasis (Metastasis) 06/2020 - 06/2015
3	Neoplasms (Cancer) 01/2020 - 01/2016
3	Friedreich Ataxia (Friedreich's Ataxia) 09/2014 - 08/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 05/2014
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 11/2019
2	Catatonia 01/2020 - 01/2019
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2020 - 10/2017
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2020 - 01/2019
2	Cognitive Dysfunction 01/2018 - 06/2015
1	Atrophy 01/2021
1	Aphasia (Dysphasia) 01/2021
1	Ischemic Stroke 04/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Cerebral Infarction 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Autism Spectrum Disorder 01/2020
1	Multiple Sclerosis 01/2020
1	Dystonia 12 11/2019
1	Dizziness (Lightheadedness) 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Hallucinations (Hallucination) 01/2019
1	Ischemia 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Paranoid Disorders (Paranoia) 01/2019
1	Seizures (Absence Seizure) 01/2019
1	Relapsing-Remitting Multiple Sclerosis 12/2018
1	Sleep Deprivation 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Dementia (Dementias) 01/2018
1	Hemorrhage 03/2016
1	Arthrogryposis renal dysfunction cholestasis syndrome 06/2015
1	Paresis (Hemiparesis) 02/2015
1	Hydrocephalus (Hydrocephaly) 02/2015
1	Synovial Cyst 11/2014
1	Disease Progression 05/2014
1	Ataxia (Dyssynergia) 08/2013
1	Hypothermia 01/2013
1	Air Embolism (Gas Embolism) 01/2013
1	Task-Specific Focal Dystonia 08/2007
1	Primary Cervical Dystonia 08/2007
1	Dystonia (Limb Dystonia) 08/2007

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 01/2020 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2019
2	Antinuclear AntibodiesIBA 01/2020 - 01/2019
2	Erythropoietin FDA Link 09/2014 - 05/2014
2	FrataxinIBA 05/2014 - 08/2013
1	ponceau 4R (E 124)IBA 01/2022
1	Capsules (Microcapsules)IBA 01/2021
1	Biological ProductsIBA 06/2020
1	EpitopesIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2019
1	SteroidsIBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	Interferon-betaIBA 12/2018
1	Pharmaceutical PreparationsIBA 12/2018
1	Oxazepam (Serax)FDA LinkGeneric 01/2018
1	Inositol (Myoinositol)IBA 02/2017
1	hydroxide ionIBA 03/2016
1	Biomarkers (Surrogate Marker)IBA 05/2014
1	FHDIBA 08/2007

Therapy/Procedure

7	Therapeutics 08/2021 - 05/2014
4	Radiotherapy 01/2021 - 06/2015
2	Deep Brain Stimulation 01/2021 - 11/2019
2	Thrombectomy 04/2020 - 06/2018
2	Ventriculostomy 01/2020 - 10/2017
2	Catheters 10/2017 - 02/2015
1	Electrodes (Electrode) 11/2019
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2015
1	Synovectomy 11/2014
1	Aftercare (After-Treatment) 09/2014
1	Hyperbaric Oxygenation 01/2013
1	Induced Hypothermia 01/2013